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Abstract
Background: This study explores (1) differences in socio-demographic, social/familial, and health variables and
perceived quality of life (QoL) among partners of patients with somatic illness, mental illness, or substance use
disorder (SUD); and (2) identifies factors associated with QoL.
Methods: Participants (N = 213) in this cross-sectional study were recruited from inpatient or outpatient services in
five hospitals in Norway, 2013–2014. QoL was measured by the QoL-5, a generic five-item questionnaire. Differences
between groups were examined using Chi-square for categorical variables and Kruskal-Wallis for contiuous variables.
Multiple linear regression analyses were used to examine factors associated with QoL.
Results: The mean QoL score was similar to that of a general population sample, and 13% of the sample had a
markedly low QoL. Partners in the SUD group experienced worse socio-demographic conditions in terms of
occupation and income, but QoL did not differ significantly among the three groups. In a regression model,
perceived family cohesion was positively associated with QoL while psychological distress (Symptom Checklist-10)
was negatively related to it. The model explained 56% of the variance in QoL.
Conclusions: When patients are ill, clinicians should consider the partners’ QoL, and brief QoL tools can be used to
identify those who are struggling most. Reduced QoL is associated with higher psychological distress and lower
family cohesion. Treatment initiatives focusing on these themes may serve as preventive measures to help the most
vulnerable families cope with their difficult life situation.
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Background
An estimated 30–50% of the general population in
Norway will experience a mental disorder in their life-
times, 10–20% will experience a substance use disorder
(SUD), and about 30% will experience cancer [1]. Thus,
during their lifetimes, many people will experience an ill-
ness of a partner or other loved one across different illness
domains. The illness not only will affect the patient but
also will impact the partner, and several studies have
found that the partner’s quality of life (QoL) is negatively
affected and typically lower than that of the general popu-
lation [2, 3]. According to some studies, partner QoL can
be even lower than that of the patient [2, 4].
QoL can be affected for several reasons. A loved one’s
illness may raise concerns and worries about the future
[2], which in turn can lead to stress, fatigue, and sleep
deprivation [2, 5]. Such factors can influence physical
and mental health negatively, and anxiety and depression
can be among the consequences [6–8]. Physical and
mental health form two integral components of QoL
[9, 10], and when they are affected, QoL will typically
be perceived as impaired.
Another typical component of QoL is the social domain,
or how people rate their social relations [11]. A stressful
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event such as the illness of a loved one can be hard to deal
with especially for partners who have no one with whom
to share their problems [12–14]. Conversely, higher per-
ceived social support has consistently been associated with
higher QoL [2, 3, 14, 15]. Social life within the family is
often affected as well; family cohesion may become
disrupted, and the partner’s familial capacity can be
weakened, as when the partner’s care is directed to-
wards the needs of the patient at the expense of the
needs of children in the household [16, 17]. Several
studies have reported correlations between QoL and
impaired family life [2, 5, 14].
Studies also have examined the association between
socio-demographic variables and the QoL of those who
have an ill partner [5–7, 14, 18]. Although there is no
obvious reason why gender, for example, would be asso-
ciated with higher or lower QoL, some studies suggest
that the QoL of female partners is more affected than
that of male partners [5, 8, 14]. Likewise, other socio-
demographic variables and QoL might not be expected
to interact automatically – i.e., people can be content
with their lives despite difficult life circumstances [9] –
but adverse life conditions such as unemployment,
higher financial burdens, or poverty would add to the
strain when people experience stressful life events such
as a loved one’s illness. Factors like these could reduce
the ability to cope with the situation and in turn nega-
tively affect QoL, as some studies also have suggested [2,
5, 12]. Lack of engagement in work and/or school activ-
ity in themselves negatively affect QoL in a normative
population [19]. More specifically, partners of mentally
ill patients or SUD patients often experience stigma at-
tached to the illness or substance abuse [20, 21], and
some may even report overwhelming feelings of guilt
and shame [22, 23]. Such additional emotional burdens
may cause partners, especially in these two illness do-
mains [24], to withdraw from social networks, further
eroding QoL.
In this study, we compared QoL in partners of patients
with illness across several illness domains, including
somatic health, mental health, and SUD. To our know-
ledge, no studies have addressed this question by com-
paring these domains in this way. We hypothesized that:
1. Partners of ill patients would have a lower QoL
compared to the normative population.
2. Partners of patients with mental illness or SUD
would have a lower QoL compared to partners of
patients with somatic illnesses.
The study aims were to (1) explore differences in
socio-demographic, social/familial, and health variables
and perceived QoL between partner groups and (2) to
identify factors associated with QoL.
Methods
Study setting
This study used data from a Norwegian cross-sectional,
multicenter study in which the overall objective was to ex-
plore the experience of children when one of their parents
has an illness, their perceived need for support, and to
what extent they receive support. Both parents (the patient
and the other parent) were included to give collateral infor-
mation about the child and to report on their own situ-
ation during illness [25]. Thus, the main study consisted of
the child, the patient with the illness, and the other bio-
logical parent who was or had been the partner of the pa-
tient. The study had a broad perspective and set out to
examine the children’s situations across illness domains
within the specialist health care services, i.e., in somatic
health (severe neurological conditions or cancer), mental
health, and SUD treatment services. Participants were re-
cruited in five Norwegian hospitals. The present study used
a subset of these data to examine the sample of partners.
Sample
The partners were recruited via patients in the main
study (see above). The patients gave consent to inclusion
of partners, and those partners willing to participate
gave written informed consent. Respondents were life
partners of the patients of the main study, and they
shared parenthood responsibilities. As the present study
focused on the QoL of partners, we did not include par-
ents that were separated or divorced. Partners who could
not read and write Norwegian were excluded.
Of the 534 families included in the main study, 266 part-
ners or ex-partners consented to participate (50%) and
213 (40%) still remained life partner of the patient. In
cases of non-inclusion, the patient did not consent to in-
vite the partner to the study or the partner was not willing
to participate. The proportion in each category is not
known because of insufficient administrative routines, but
the inclusion rate in the mental health and SUD illness
domains was lower than in the somatic domain (36%,
19%, and 57%, respectively; χ2 = 51.7, p < 0.001).
Data collection
The participants were recruited from March 2013 to
December 2014. Recruitment and data collection were
carried out by a local coordinator and co-workers at
each hospital. Data collection was conducted according
to participant choice, usually at their home. Responses
to questionnaires that required about one hour to
complete were entered on tablets.
Measures and procedures
We included a number of demographic and social indicator
variables reflecting living conditions, which may advanta-
geous when examining QoL [26]. In this study, age, gender,
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work/school status, educational level, and income were ex-
amined. Occupation and ongoing education, i.e., work/
school status, was summarized into an indicator for activity
(percentage engaged in work/school), following the ex-
ample of Barstad [27].
Social and familial variables
Social support As mentioned, the perceived available so-
cial support can be important for how a person copes with a
stressful life event and may therefore be an important pre-
dictor for perceived QoL in such circumstances. In the ana-
lysis, we have placed “social support” and “family cohesion”
(see below) under the headings “social/familial variables.”
Social support was measured using the Interpersonal Sup-
port Evaluation List (ISEL), which includes 12 items on so-
cial support in both daily life and crises [28]. This
instrument is an instrument used to measure the perceived
availability of four subscales (Belonging Support, Self-esteem
Support, Tangible Support, and Appraisal Support), and the
response options range from 1 to 4, with a sum score of 12
to 48; higher scores indicate higher perceived support. There
is no generally accepted cut-off for high versus low per-
ceived social support in ISEL. The mid-point of the scale is
30, and scores above that value indicate a more positive than
negative view of the amount of social support available [29].
In a US-based general population sample, the mean score
was 42.7 (5.0) [30]. The instrument has been used in several
countries [31, 32], including Norway [33].
Family cohesion Family cohesion was measured using
the Family Cohesion Subscale (FACES-III) [34, 35], with
10 items describing relations among family members and
the degree to which family members feel separated from
or connected to their family. The responses range from 1
to 5, with a sum score from 10 to 50 and higher scores in-
dicating higher cohesion. A mean score of 39.8 has been
found in a general population [36], and a score below 40
indicates perceived lack of cohesion. The Norwegian ver-
sion has been validated and found to be usable [33].
Partner’s perceived family capacity To measure whether
the partner’s care was directed towards the illness of the
patient at the expense of the children and partner’s own
needs, the main study’s project group constructed a set
of eight questions for the present investigation. The
questions were informed by a qualitative study among
Norwegian families with substance use problems [37].
The questions began with the phrase, “Does the condi-
tion of the ill parent affect your capacity to…” and were
completed with phrases covering eight domains, e.g., “do
practical housework,” “…give the children emotional
support,” “…give the children structure,” and “…partici-
pate in social activities with the children.” The questions
were scored on a 4-point scale (0 = not at all, 1 = slightly,
2 = to some degree, 3 = to a larger degree). A high score
indicates a high influence of the condition/disease on the
capacity of the partner in the family. The factor structure
of this new scale was examined with an exploratory factor
analysis using principal axis and an oblique rotation
method (promax). Kaiser’s eigenvalue-greater-than-one
rule was used to determine the number of factors, and
items were retained if they had factor loadings >0.4 [38].
The analysis yielded a univariate solution, and only one
factor was extracted; all items had factor loadings above
0.57, and the scale explained 67% of the variance. The
Cronbach’s alpha was 0.93.
Concerns about child/children The partner’s level of
concern about their children, i.e., worries about their well-
being and functioning, was measured using a single ques-
tion: “Do you have any concerns about your child’s well-
being and functioning?” The question was scaled similarly
to the family capacity scale, and a higher score indicated a
greater concern for the child. No normative data for this
single item exist, as it has been used only in this study.
Health variables
Psychological distress Perceived psychological distress
was measured using the Hopkins Symptom Checklist 10
(SCL-10), a short-form of the Hopkins Symptom Check-
list 90 [39], which has 10 items about anxiety (4 items)
and depression (6 items). Responses were scored on an or-
dinal scale from 1 to 4, with the highest score indicating
highest distress. A total mean score above 1.85 is consid-
ered a pathological score, with a mean score of 1.36 in a
general population [40, 41]. The SCL-10 assessment is
considered to provide a good indicator of psychological
distress and is validated and considered suitable for use in
Norway [40].
Substance use Substance use and substance use prob-
lems in participants were measured with the CAGE
questionnaire Adapted to Include Drugs (CAGE-AID)
[42]. This instrument includes use of legal and illegal
substances, as well as legal substances used in a way
other than prescribed. A sum score based on four ques-
tions (“yes/no”) was calculated (range 0–4), and a score
of 2 or higher indicates a substance use problem [42]. A
mean score of 0.9 was found in a hospital population
sample of non-SUD patients [43]. National guidelines for
assessment of substance use in Norway recommend
CAGE-AID as an assessment tool [44].
Quality of life (QoL)
QoL was measured with the QoL-5 [45], a generic, vali-
dated instrument covering overall QoL, based on an in-
tegrative theory of QoL and considered relevant as a
disease-nonspecific instrument [45–47]. The reason for
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choosing the QoL questionnaire was that the instrument
has been described as useful for measuring the overall
QoL for both general population samples and across dif-
ferent illness domains [45, 46, 48]. It consists of five sub-
jective QoL statements: two questions on mental and
physical health, two questions on the quality of the rela-
tionship with important others (partner and friends), and
one question regarding existential QoL, meaning relation
to self. Responses are scored on a five-step ordinal scale
ranging from very poor to very good QoL, and then trans-
ferred to a decimal scale from 0.1 to 0.9, where 0.9 is the
highest/best score and 0.1 the lowest/worst [45, 49]. Mean
scores for health, relationships, and existential QoL were
calculated, as was a total QoL score as a mean of the three
scores. A mean score of 0.69 was found in a previous sur-
vey of the general population and was used as our popula-
tion reference [45]. The cut-off score for a markedly low
QoL has been suggested to be −0.15 below the general
population (<0.55) [47]. The instrument has been used in
a number of studies and is sensitive to QoL changes and
for capturing differences in QoL; it has also been estab-
lished as a valid and reliable instrument [45, 47, 50].
Statistical analyses
Descriptive statistics were used to present sample charac-
teristics. Differences between groups were examined using
Chi-square for categorical variables. The Kolmogorow-
Smirnov test was implemented to ascertain whether con-
tinuous variables were or were not normally distributed.
Since the criteria for a normal distribution were not ful-
filled, the nonparametric Kruskal-Wallis test was used for
the inter-group comparisons. If significant, results were
followed up with a Mann-Whitney U-test. Before the mul-
tiple regression analysis, preliminary bivariate analyses
were used to examine factors associated with QoL; factors
with a p value below 0.20 were included in the following
sequential procedure following the lax criterion recom-
mended by Altman [51]. A stepwise procedure (hierarch-
ical regression) was used to examine the relative influence
on QoL of socio-demographic, social/familial, and health
variables. In the first step, we included socio-demographic
variables (group, gender, education, work/school activity,
and income). In the second step, we included social/famil-
ial variables (family cohesion, social support, concern for
child, and whether the familial capacity was influenced by
the illness). Finally, in the last step, we added health vari-
ables (psychological distress). The dependent variable
(QoL) was expected to be skewed toward the higher end
of the scale; thus, a bootstrapping procedure (1000 repli-
cations) was used to obtain more robust estimates. Results
are presented as unstandardized beta coefficients with
95% confidence intervals (CIs). The R square (R2) value
was used to assess the fit of the statistical model. Analyses
of variables were considered to be statistically significant
at p < 0.05. All analyses were performed using IBM SPSS
Statistics version 21.
Results
Differences between partner groups
The total sample consisted of 213 partners: 116 in the
somatic illness domain, 72 in the mental illness domain,
and 25 in the SUD domain (Table 1). We found significant
differences across groups. The proportion of women was
higher in partners in the SUD group. Partners in this
group also reported having significantly lower income,
lower education level, and less work/school activity.
The mean score on the family cohesion scale (FACES-
III) was above the cut-offs for lack of cohesion and on the
positive side of the social support scale (ISEL). The part-
ners’ perceived capacity in the family was affected only
modestly by the illness of the patient, as evidenced by a
mean score close to the term “slightly affected” on the
scale. There were no significant differences across groups
in these variables. In terms of concern for the child/chil-
dren in the family; the participants had little worry for the
child (a mean score of ≤1 on the scale), with the lowest
score in the SUD group.
In terms of health variables, only 7 (3%) scored above
the cut-off the for severe substance use problems (CAGE-
AID), with a slightly higher proportion of problematic
substance use in the SUD partner group. Regarding per-
ceived psychological distress (SCL-10), the mean score
(1.44, SD 0.50) was below the pathological cut-off for all
three groups, with 39 (18%) participants scoring above the
cut-off for psychological distress. No differences in per-
ceived psychological distress (SCL-10) emerged among
the three groups.
QoL scores were similar to those of the normative
population for the sample as a whole (0.71, SD 0.14),
with no significant differences among groups (Table 1).
A small proportion of the sample (13%) reported a
markedly low QoL (<0.55).
Variables associated with QoL
In bivariate analyses, age and substance use (CAGE-
AID) had p-values above the recommended lax criterion
(p > 0.2); thus, they were excluded from further analyses
and from the following model.
The first step of the hierarchical regression (socio-
demographic variables) (Table 2) showed that income and
work/school activity were significantly associated with
QoL. This model explained 6% (R2) of the variance. In the
second step of the hierarchical regression, we added so-
cial/familial variables; family cohesion (FACES-III), per-
ceived social support (ISEL), and perceived worry/concern
about the child/children were significantly associated with
QoL (Table 2). This model explained 33% (R2) of the vari-
ance in QoL. The final model included health variables,
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and only two variables were significantly associated with
QoL: perceived family cohesion and psychological distress.
Perceived family cohesion was positively associated with
QoL while psychological distress (SCL-10) was a negative
predictor (beta = −0.16; 95% CI = −0.20/−0.13, p < 0.001;
Table 2). The final model explained 56% (R2) of the vari-
ance in QoL (Table 2).
Discussion
Some socio-demographic variables differed significantly
among the groups in this study; partners in the SUD
group differed significantly in terms of gender (being fe-
male), lower work/school activity, lower educational level,
and lower income. The QoL score for the total sample
was similar to that of a normative population sample, with
no significant differences in QoL among groups. In a re-
gression model, perceived family cohesion was positively
associated with QoL whereas psychological distress was
negatively related to it. The model explained 56% of the
variation in QoL.
The normality of the QoL scores in this population
was unexpected in light of the known strain of having
an ill partner [8, 12, 14, 18]. Previous studies among
partners to ill patients showed that if the patient re-
ceived treatment, the impact on the partner’s QoL was
positive [8, 52, 53]. Our participants were recruited dur-
ing a treatment period for the ill parent, which may in
part explain the unexpectedly high QoL in our sample.
However, in the long run, treatment does not necessarily
lead to a better QoL in the partner if the patient does
not have a remission [6, 53, 54]. Nonetheless, 13% re-
ported a markedly low QoL. This finding indicated that
a relatively small proportion of the sample seemed to
struggle more with their life situation.
The lack of significant differences in QoL between groups
was also surprising and was contrary to our hypothesis. The
partners in the SUD group were worse off in terms of some
socio-demographic conditions; for example, they were less
likely to being occupied with work or school, and had a
poorer educational level and income than the other two
Table 1 Characteristics of participants (N = 213), with data presented as N (%) or mean (SD) / median (Interquartile range, IQR) [italics]
Variables Somatic group (A)
N = 116
Mental illness
group (B) N = 72
Substance use (SUD)
group (C) N = 25
Total N = 213 p valuea A / Bb A / Cb B / Cb
Age, years 43 (7)/
43 (9)
39 (8)/
38 (15)
36 (10)/
35 (15)
41 (8)/
41 (12)
<0.001 0.004 0.001 ns.
Gender, women 35 (30) 13 (18) 16 (64) 100 (38) <0.001 ns. 0.001 <0.001
Work/school activityc 89 (26)/
109 (94)
85 (33)/
63 (88)
52 (46)/
15 (60)
83 (33)/
187 (88)
<0.001 ns. <0.001 0.003
Educational level
- Primary education 13 (11) 5 (7) 6 (24) 24 (11)
- High school 37 (32) 36 (50) 14 (56) 87 (41) 0.003 0.044 0.003 0.023
- College/university 66 (57) 31 (43) 5 (20) 102 (48)
Incomed 986′ (439)/
900′ (380)
770′ (271)/
700′ (250)
481′ (224)/
450′ (210)
849′ (403)/
800′ (385)
<0.001 <0.001 <0.001 <0.001
Social support (ISEL) 38.2 (6.2)/
38.5 (10.8)
37.3 (7.3)/
37.0 (10.8)
37.2 (6.9)/
38.0 (13.0)
37.8 (6.7)/
38.0 (10.0)
0.767
Family cohesion (FACES-III) 42.3 (5.4)/
43.0 (8.0)
41.4 (5.9)/
42.0 (9.8)
40.6 (8.0)/
41.0 (9.5)
41.8 (6.0)/
43.0 (9.0)
0.649
Perceived family capacity
influenced by patient’s illnesse
0.9 (0.8)/
0.8 (1.5)
1.2 (1.0)/
1.0 (1.8)
1.0 (0.9)/
0.6 (1.5)
1.0 (0.9)/
0.9 (1.5)
0.053
Perceived concern for childrenf 0.9 (0.9)/
1.0 (2.0)
1.0 (1.1)/
0.0 (2.0)
0.4 (0.8)/
0.0 (0.0)
0.8 (1.0)/
0.0 (2.0)
0.036 ns. 0.013 0.017
Substance use (CAGE-AID),
cut-off >2
2 (2) 2 (3) 3 (12) 7 (3) 0.031 ns. 0.012 ns.
Perceived psychological
distress (SCL-10)
1.42 (0.43)/
1.30 (0.68)
1.49 (0.58)/
1.30 (0.80)
1.40 (0.55)/
1.20 (0.40)
1.44 (0.50)/
1.30 (0.70)
0.877
Quality of Life (QoL-5) 0.72 (0.13)/
0.73 (0.17)
0.68 (0.16)/
0.68 (0.23)
0.73 (0.13)/
0.73 (0.20)
0.71 (0.14)/
0.70 (0.23)
0.122
ap value obtained from Chi-square tests or Kruskal-Wallis
bWhen the three group tests were significant, results were followed up with paired comparisons. p value obtained from Chi-square or Mann-Whitney U-test.
The term ns. means non-significance
cPercentage engaged in work/school
dIncome in 1000 NOK
eScale 0–3; higher score indicates that the condition of the ill parent had a higher impact on the other parent’s family capacity
fScale 0–3; higher score indicates a higher concern for the child’s/children’s situation
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groups, but these findings were not reflected in a poorer
QoL at the group level. In general, poorer socio-demographic
conditions seem to affect QoL negatively [9]; however, the
subjective experience of such conditions affects QoL more
than the ‘objective’ differences [55]. Thus, in line with other
research [56, 57], overall QoL is more than a measurement
of objective demographic conditions; it reflects how the indi-
vidual relates to these conditions. An alternative explanation
may be that when the patient receives treatment, a partner in
the SUD group experiences a relatively greater relief from
worries and burdens and perhaps perceives a temporal relief
from their worries [54]. Thus, their QoL score may have been
overestimated at this specific point in time.
Family cohesion were retained as significant factors as-
sociated with QoL in the final regression model. This
outcome has been seen in previous studies among part-
ners of patients with illness and accentuates the import-
ance of perceived proximity and cohesion in close
relations to retain the QoL [2, 14, 54]. The experience of
instability and insecurity that partners of ill patients re-
port may affect perceived family cohesion and also
underlie the negative influence on QoL [5, 14].
Psychological distress (SCL-10) was the strongest vari-
able explaining variations in QoL. A one-point gain
(higher psychological distress) resulted in a 0.16 lower
QoL-5 score in the final adjusted model, suggesting a sub-
stantial influence when applying the clinical interpretation
of the scale [46]. The fit of the model was also strength-
ened considerably, and the explained variance in QoL in-
creased from 33% to 56% with inclusion of this clinical
variable. Feelings of hopelessness, worry, stress, and de-
pression have been observed in partners of somatic or
mentally ill patients [12, 18], as has anxiety in relatives of
SUD patients [4, 6]. Such negative emotions may underlie
the psychological distress reported here, which in turn
strongly predicted worse QoL. High psychological distress
would likely make an individual less able to cope well with
a difficult situation arising when a close relative suffers
from an illness. Other studies also report strong correla-
tions between psychological distress and poor QoL [2, 6–
8, 52], affirming the findings of our final model. However,
with the present design, we cannot discern whether the
reported psychological distress existed before the illness
or was a reaction to having an illness in the family.
Methodological considerations
The strengths of the study include an acceptable sample
size and inclusion of groups of respondents who have not
been compared before; previous studies tend to focus on
separate domains. However, some limitations must be kept
in mind. The sample size per group may not have been
large enough for detecting statistical significant differences
between them. Furthermore, the participants were recruited
while the ill parent was in treatment, which might limit the
representativeness of the findings. The participants in most
benchmark studies in this field have an average age at least
10 years greater than in our study [7, 8, 12–14, 53]. The
sample is therefore mainly representative of middle-aged
partners and time periods when the ill parent is enrolled in
treatment. Although socio-demographic variables differed
among the groups, the findings indicate that we did not
recruit respondents with extreme economic or social
disturbances in their lives. One possible question is if those
who did not participate experienced more disturbances
Table 2 Factors associated with QoL (N = 266)
Variables Block 1b Block 2b Block 3b
Socio-demographic variables B (95% CI) p valuea B (95% CI) p valuea B (95% CI) p valuea
Groupc 0.02 (−0.01/0.05) 0.141 0.02 (−0.01/0.04) 0.242 0.00 (−0.02/0.03) 0.715
Gender −0.02 (−0.07/−0.02) 0.279 −0.03 (−0.07/0.01) 0.141 −0.01 (−0.04/0.03) 0.758
Education 0.01 (−0.02/0.04) 0.431 0.01 (−0.02/0.04) 0.498 0.00 (−0.02/0.03) 0.760
Work/school activityd 0.00 (0.00/0.00) 0.050 0.00 (0.00/0.00) 0.241 0.00 (−0.00/0.00) 0.669
Incomee 0.01 (0.00/0.01) 0.030 0.00 (−0.00/0.01) 0.180 0.00 (−0.00/0.01) 0.437
Social / familial variables
Family cohesion (FACES-III)f 0.05 (0.02/0.08) 0.003 0.05 (0.02/0.07) 0.001
Social support (ISEL)g 0.07 (0.03/0.10) 0.001 0.03 (−0.00/0.06) 0.091
Concern about child
Family capacity
−0.03 (−0.05/−0.01)
−0.01 (−0.04/0.01)
0.002
0.186
−0.01 (−0.03/0.01)
−0.01 (−0.02/0.01)
0.206
0.558
Health variables
Psychological distress (SCL-10) −0.16 (−0.20/−0.13) <0.001
ap value obtained from multivariate linear regression, presented as beta and 95% confidence interval (CI)
bExplained variance (R2): Block 1 (socio-demographic variables) = 6%; Block 2 (social/familial variables) = 33%; Block 3 (health variables) = 56%
cGroups: Partners of patients in three domains – somatic or mental illness or substance use disorders
dPercentage engaged in work/school activity
eIncome in NOK 100,000
f,gMean scores were used to facilitate interpretation of the coefficients
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compared to those who did [12]. The attrition analysis
showed that there was a lower inclusion rate in the mental
health and SUD illness domain, indicating that our results
may be positively biased in these two illness domains. Fur-
ther attrition analysis was not possible because administra-
tive data on non-inclusion were insufficiently registered.
The limited sample size per group also prevented us from
examining whether there were different associations be-
tween independent variables and QoL across groups, i.e.
with separate regression analyses for each group. In spite of
the limitations, the findings provide important information
about obstacles and facilitators of QoL in partners, which
may be informative for further research and interventions.
Implications
Although the findings indicate that the sample as a whole
reported a QoL score in line with the general population,
some respondents still reported a markedly low QoL. We
suggest that such brief QoL tools can be used to capture
those who are struggling most with their life situation.
Conclusions
Treatment services should include consideration of the
partners in times of illness of patients, and short QoL as-
sessments can be one way of identifying those with a need
for particular support. For these partners, the findings of
the present study suggest the most important themes that
clinicians should address: family cohesion and psychological
vulnerability. Treatment initiatives focusing on these
themes may serve as preventive measures to help the most
vulnerable families cope with their difficult life situation.
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